News for Jaguar Health, Inc. (JAGX)

MIAMI, July 16, 2025 (GLOBE NEWSWIRE) -- EmergingGrowth.com a leading independent small cap media portal announces the schedule of the 84th Emerging Growth Co

MIAMI, July 15, 2025 (GLOBE NEWSWIRE) -- EmergingGrowth.com a leading independent small cap media portal announces the schedule of the 84th Emerging Growth Co

MIAMI, July 15, 2025 (GLOBE NEWSWIRE) -- EmergingGrowth.com a leading independent small cap media portal announces the schedule of the 84th Emerging Growth Conference on July 16 & 17, 2025.

Company strategy: In discussions with multiple potential animal health company partners to collaborate to bring Canalevia®, conditionally approved for CID, to

Jaguar Health (JAGX) has made progress in its ongoing field study of Canalevia-CA1, a conditionally approved drug by the U.S. FDA for treating chemotherapy-indu

Strategic decision positions Jaguar to diversify treasury holdings with a long-term digital store of value SAN FRANCISCO, CA / ACCESS Newswire / June 26, 2025 /

Jaguar Health (JAGX) to diversify its treasury by including cryptocurrency as a reserve asset. The decision aims to capitalize on potential upside and p

Enrollment in company's first-of-its-kind placebo-controlled Phase 2 study to evaluate the efficacy of crofelemer for microvillus inclusion disease (MVID) in pe

Jaguar Health (JAGX) has submitted an application to offer 507,400 shares of its common stock. This move is part of a broader strategy to facilitate current sha

Jaguar Health (JAGX) has initiated a prospectus for existing shareholders to resell 507,400 common stock shares. The company's analysts maintain a stron

Click here to register SAN FRANCISCO, CA / ACCESS Newswire / June 17, 2025 / Jaguar Health, Inc. (NASDAQ:JAGX) today announced that Lisa Conte, the company's fo

MIAMI, June 17, 2025 (GLOBE NEWSWIRE) -- EmergingGrowth.com a leading independent small cap media portal announces the schedule of the 83rd Emerging Growth Co

**media[657052]**

MIAMI, June 16, 2025 (GLOBE NEWSWIRE) -- EmergingGrowth.com, a leading independent small cap media portal, announces the schedule of the 83rd Emerging Growth

Click here to registerDiscussion will focus on company's May 2025 meeting with the FDA to review the statistically significant responder analysis results for th

Jaguar Health (JAGX) recently summarized outcomes from its Type C Meeting with the U.S. Food and Drug Administration's Division of Gastroenterology on May 28, 2

Significant milestone for Jaguar Health (JAGX) as FDA discusses potential approval pathways for crofelemer. Breast cancer patient subgroup in Phase 3 tr

Click here to register SAN FRANCISCO, CA / ACCESS Newswire / June 6, 2025 / Jaguar Health, Inc. (NASDAQ:JAGX) today announced that Lisa Conte, the company's fou

Key Highlights: Jaguar Health's (JAGX) upcoming virtual fireside chat is part of Lytham Partners' Spring 2025 Spotlight Series.